Urologic Oncology: Seminars and Original Investigations

eISSN: 1873-2496pISSN: 1078-1439

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
4.7
H-Index
79
Impact Factor
< 5
SJR
Q1Urology
SNIP
1.01
4
Time to Publish
time-to-publish View Chart
5  Mo

Journal Specifications

Overview
  • Publisher
    ELSEVIER SCIENCE INC
  • Language
    English
  • Frequency
    Monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 17%
4-6 57%
7-9 22%
>9 5%

Topics Covered

Bladder cancer
Prostate cancer
Clinical significance
Prostate-specific antigen
Progression-free survival
Renal function
Overall survival
Penile cancer
Curative intent
Renal carcinoma
Immune checkpoint inhibitors
Prostate biopsy
Systematic review
Prostatectomy
Social support
Cystoscopy
Magnetic resonance imaging
Urologic Oncology
Immunohistochemistry
Gemcitabine

Year-wise Publication

FAQs

Since when has Urologic Oncology: Seminars and Original Investigations been publishing? Faqs

The Urologic Oncology: Seminars and Original Investigations has been publishing since 2003 till date.

How frequently is the Urologic Oncology: Seminars and Original Investigations published? Faqs

Urologic Oncology: Seminars and Original Investigations is published Monthly.

What is the H-index. SNIP score, Citescore and SJR of Urologic Oncology: Seminars and Original Investigations? Faqs

Urologic Oncology: Seminars and Original Investigations has a H-index score of 79, Citescore of 4.7, SNIP score of 1.01, & SJR of Q1

Who is the publisher of Urologic Oncology: Seminars and Original Investigations? Faqs

The publisher of Urologic Oncology: Seminars and Original Investigations is ELSEVIER SCIENCE INC.

How can I view the journal metrics of Urologic Oncology: Seminars and Original Investigations on editage? Faqs

For the Urologic Oncology: Seminars and Original Investigations metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Urologic Oncology: Seminars and Original Investigations? Faqs

The eISSN number is 1873-2496 and pISSN number is 1078-1439 for Urologic Oncology: Seminars and Original Investigations.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Bladder cancer, Prostate cancer, Clinical significance, Prostate-specific antigen, Progression-free survival, Renal function, Overall survival, Penile cancer, Curative intent, Renal carcinoma, Immune checkpoint inhibitors, Prostate biopsy, Systematic review, Prostatectomy, Social support, Cystoscopy, Magnetic resonance imaging, Urologic Oncology, Immunohistochemistry, Gemcitabine.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.